{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:31:54Z","timestamp":1780522314196,"version":"3.54.1"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["306987\/2021-0"],"award-info":[{"award-number":["306987\/2021-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.pnpbp.2024.110951","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T21:44:43Z","timestamp":1706823883000},"page":"110951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Therapeutic potential of psychedelics: History, advancements, and unexplored frontiers"],"prefix":"10.1016","volume":"131","author":[{"given":"Juliana Marino","family":"Maia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Stefane Alves","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz G.S.","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato Nery","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2024.110951_bb0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01224-X","article-title":"Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release","volume":"825","author":"Aghajanian","year":"1999","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110951_bb0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn2648","article-title":"Stress signalling pathways that impair prefrontal cortex structure and function","volume":"10","author":"Arnsten","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archpsyc.1959.03590030063008","article-title":"Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148","volume":"1","author":"Balestrieri","year":"1959","journal-title":"A.M.A. Archiv. Gen. Psychiatr."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.110951_bb0020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/0269881116678781","article-title":"The challenging experience questionnaire: characterization of challenging experiences with psilocybin mushrooms","volume":"30","author":"Barrett","year":"2016","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173129","article-title":"Use and abuse of dissociative and psychedelic drugs in adolescence","volume":"203","author":"Bates","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.110951_bb0030","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/s41386-023-01574-8","article-title":"The effect of lysergic acid diethylamide (Lsd) on whole-brain functional and effective connectivity","volume":"48","author":"Bedford","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110951_bb0035","first-page":"120","article-title":"A high-resolution in vivo atlas of the human Brain\u2019s serotonin system","volume":"37","author":"Beliveau","year":"2017","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.110951_bb0040","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/scan\/nsq080","article-title":"Depression, rumination and the default network","volume":"6","author":"Berman","year":"2011","journal-title":"Soc. Cogn. Affect. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229067","article-title":"Self-reported negative outcomes of psilocybin users: A quantitative textual analysis","volume":"15","author":"Bienemann","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110951_bb0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"Journal of psychopharmacology (Oxford, England)"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110951_bb0055","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00221-013-3512-6","article-title":"Functional anatomy of 5-HT2A receptors in the amygdala and hippocampal complex: relevance to memory functions","volume":"230","author":"Bombardi","year":"2013","journal-title":"Exp. Brain Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110951_bb0065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2265.2007.02976.x","article-title":"Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men","volume":"67","author":"Brambilla","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpsychires.2022.03.008","article-title":"MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD","volume":"149","author":"Brewerton","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0075","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69320","article-title":"Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD","volume":"10","author":"Burt","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0080","first-page":"241","article-title":"L.S.D. 25 as an aid in psychotherapy; preliminary report of a new drug","volume":"11","author":"Busch","year":"1950","journal-title":"Dis. Nerv. Syst."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110951_bb0085","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","article-title":"Chronic, intermittent microdoses of the psychedelic n, n -dimethyltryptamine (Dmt) produce positive effects on mood and anxiety in rodents","volume":"10","author":"Cameron","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"6579","key":"10.1016\/j.pnpbp.2024.110951_bb0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"vol. 375","author":"Cao","year":"2022","journal-title":"Science (New York, N.Y.)"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.110951_bb0095","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2018.03.010","article-title":"The entropic brain - revisited","volume":"142","author":"Carhart-Harris","year":"2018","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110951_bb0105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol. Rev."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.110951_bb0110","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.110951_bb0115","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: A tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110951_bb0120","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front. Hum. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110951_bb0130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110951_bb0135","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: FMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0140","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110951_bb0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nrl.2011.07.003","article-title":"Hallucinogenic drugs in pre-Columbian Mesoamerican cultures","volume":"30","author":"Carod-Artal","year":"2015","journal-title":"Neurologia (Barcelona, Spain)"},{"issue":"8","key":"10.1016\/j.pnpbp.2024.110951_bb0150","doi-asserted-by":"crossref","first-page":"18474","DOI":"10.3390\/ijms160818474","article-title":"Functional selectivity and antidepressant activity of serotonin 1A receptor ligands","volume":"16","author":"Chilmonczyk","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/1570159X15666170911121027","article-title":"Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 receptors and their role in the modulation of pain response in the central nervous system","volume":"16","author":"Cortes-Altamirano","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.110951_bb0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110951_bb0165","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2023.100654","article-title":"Inhaled molecular hydrogen reduces hippocampal neuroinflammation, glial reactivity and ameliorates memory impairment during systemic inflammation","volume":"31","author":"De Deus","year":"2023","journal-title":"Brain, Behavior, & Immunity - Health"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.110951_bb0175","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1152\/japplphysiol.00424.2007","article-title":"Raphe magnus nucleus is involved in ventilatory but not hypothermic response to CO 2","volume":"103","author":"Dias","year":"2007","journal-title":"J. Appl. Physiol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/02791072.2019.1606472","article-title":"The past and future of psychedelic science: an introduction to this issue","volume":"51","author":"Doblin","year":"2019","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0190","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2147\/RMHP.S300656","article-title":"The use of classic hallucinogens\/psychedelics in a therapeutic context: healthcare policy opportunities and challenges","volume":"14","author":"Dos Santos","year":"2021","journal-title":"Risk Manag. Healthcare Policy"},{"issue":"10","key":"10.1016\/j.pnpbp.2024.110951_bb0195","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41386-022-01344-y","article-title":"Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder","volume":"47","author":"D\u2019Souza","year":"2022","journal-title":"Neuropsychopharmacology\u202f: official publication of the American College of Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.110951_bb0200","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/13634615211036388","article-title":"The socialization of hallucinations: cultural priors, social interactions, and contextual factors in the use of psychedelics","volume":"59","author":"Dupuis","year":"2022","journal-title":"Transcult. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.110951_bb0210","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/brainsci10090606","article-title":"Sex and gender differences in the effects of novel psychoactive substances","volume":"10","author":"Fattore","year":"2020","journal-title":"Brain Sci."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.110951_bb0215","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41583-018-0039-7","article-title":"Brain circuit dysfunction in post-traumatic stress disorder: from mouse to man","volume":"19","author":"Fenster","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0220","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1476-5381.1954.tb00848.x","article-title":"Drugs which antagonize 5-hydroxytryptamine","volume":"9","author":"Gaddum","year":"1954","journal-title":"Br. J. Pharmacol. Chemother."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110951_bb0225","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/advances\/nmz127","article-title":"Tryptophan metabolism: A link between the gut microbiota and brain","volume":"11","author":"Gao","year":"2020","journal-title":"Adv. Nutr."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110951_bb0230","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0235","doi-asserted-by":"crossref","unstructured":"George, J. R., Michaels, T. I., Sevelius, J., & Williams, M. T. (2019). The psychedelic renaissance and the limitations of a white-dominant medical framework: A call for indigenous and ethnic minority inclusion. J. Psychedelic Stud., 4(1), 4\u201315. Recuperado janeiro 31, 2023, de https:\/\/akjournals.com\/view\/journals\/2054\/4\/1\/article-p4.xml.","DOI":"10.1556\/2054.2019.015"},{"issue":"18","key":"10.1016\/j.pnpbp.2024.110951_bb0240","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0245","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jad.2023.01.108","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression: impact on patient-reported depression severity, anxiety, function, and quality of life","volume":"327","author":"Goodwin","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.110951_bb0250","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020705118","article-title":"Lysergic acid diethylamide (Lsd) promotes social behavior through mTORC1 in the excitatory neurotransmission","volume":"118","author":"Gregorio","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.110951_bb0255","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"Journal of psychopharmacology (Oxford, England)"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109220","article-title":"Psychedelic drug abuse potential assessment research for new drug applications and controlled substances act scheduling","volume":"218","author":"Henningfield","year":"2022","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.110951_bb0270","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0006-3223(92)90059-9","article-title":"Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research","volume":"32","author":"Hermle","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0275","series-title":"Seel (Org.), Encyclopedia of the Sciences of Learning","first-page":"590","article-title":"Cognitive efficiency","author":"Hoffman","year":"2012"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0280","series-title":"LSD: My Problem Child","author":"Hofmann","year":"1980"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110951_bb0285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02159243","article-title":"Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim","volume":"14","author":"Hofmann","year":"1958","journal-title":"Experientia"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110951_bb0290","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide\u2013assisted therapy in patients with anxiety with and without a life-threatening illness: A randomized, double-blind, placebo-controlled phase ii study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jad.2022.07.004","article-title":"At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: findings from a large, prospective, open-label effectiveness trial","volume":"314","author":"Hull","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0310","series-title":"The Doors of Perception.[on the Author's Sensations under the Influence of the Drug Mescalin.]","author":"Huxley","year":"1954"},{"issue":"8","key":"10.1016\/j.pnpbp.2024.110951_bb0315","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00213-020-05548-2","article-title":"Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials","volume":"237","author":"Jerome","year":"2020","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.110951_bb0320","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"Journal of psychopharmacology (Oxford, England)"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110951_bb0325","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0330","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbr.2011.04.025","article-title":"The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety","volume":"223","author":"Kim","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2016.00093","article-title":"The inverse relationship between the microstructural variability of amygdala-prefrontal pathways and trait anxiety is moderated by sex","volume":"10","author":"Kim","year":"2016","journal-title":"Front. Syst. Neurosci."},{"issue":"13","key":"10.1016\/j.pnpbp.2024.110951_bb0340","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.3390\/jcm12134426","article-title":"Anatomical and functional connectivity of critical deep brain structures and their potential clinical application in brain stimulation","volume":"12","author":"Kong","year":"2023","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110951_bb0345","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/02698811231158245","article-title":"Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: findings from the global drug survey 2020","volume":"37","author":"Kopra","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.110951_bb0350","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/0269881119857204","article-title":"Microdosing psychedelics: more questions than answers? An overview and suggestions for future research","volume":"33","author":"Kuypers","year":"2019","journal-title":"Journal of psychopharmacology (Oxford, England)"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0355","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jad.2022.11.090","article-title":"Patients\u2019 recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression","volume":"323","author":"Lapidos","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0360","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroimage.2017.07.020","article-title":"Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow","volume":"159","author":"Lewis","year":"2017","journal-title":"NeuroImage"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0365","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2010.03.010","article-title":"Decrease in the descending inhibitory 5-HT system in rats with spinal nerve ligation","volume":"1330","author":"Liu","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0370","article-title":"A selective review of the excitatory-inhibitory imbalance in schizophrenia: underlying biology, genetics, microcircuits, and symptoms","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Develop. Biol."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0375","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways","volume":"36","author":"L\u00f3pez-Gim\u00e9nez","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110951_bb0380","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ph3010019","article-title":"The timing of antidepressant effects: A comparison of diverse pharmacological and somatic treatments","volume":"3","author":"Machado-Vieira","year":"2010","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0385","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.euroneuro.2020.02.001","article-title":"A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding","volume":"33","author":"Madsen","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4\u20135","key":"10.1016\/j.pnpbp.2024.110951_bb0390","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s007020050064","article-title":"Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone","volume":"105","author":"Martin","year":"1998","journal-title":"J. Neural Transmission (Vienna, Austria: 1996)"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.110951_bb0395","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110951_bb0400","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0028-3908(90)90001-8","article-title":"Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes","volume":"29","author":"McKenna","year":"1990","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0405","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110951_bb0410","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110951_bb0415","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2215-0366(18)30135-4","article-title":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"5","author":"Mithoefer","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.110951_bb0420","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0425","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bbi.2017.07.010","article-title":"Central serotonin attenuates LPS-induced systemic inflammation","volume":"66","author":"Mota","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0430","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbi.2019.03.017","article-title":"Central serotonin prevents hypotension and hypothermia and reduces plasma and spleen cytokine levels during systemic inflammation","volume":"80","author":"Mota","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110951_bb0435","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13401","article-title":"Systemic serotonin inhibits brown adipose tissue sympathetic nerve activity via a GABA input to the dorsomedial hypothalamus, not via 5HT 1A receptor activation in raphe pallidus","volume":"228","author":"Mota","year":"2020","journal-title":"Acta Physiol."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112486","article-title":"Citral-induced analgesia is associated with increased spinal serotonin, reduced spinal nociceptive signaling, and reduced systemic oxidative stress in arthritis","volume":"250","author":"Mota","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110951_bb0445","doi-asserted-by":"crossref","first-page":"e1084","DOI":"10.1038\/tp.2017.54","article-title":"Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects","volume":"7","author":"Mueller","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110951_bb0450","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/acps.12818","article-title":"Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations","volume":"136","author":"M\u00fcller","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0455","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.nicl.2018.03.005","article-title":"Altered network hub connectivity after acute LSD administration","volume":"18","author":"M\u00fcller","year":"2018","journal-title":"NeuroImage. Clinical"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0460","article-title":"Treatment of a complex personality disorder using repeated doses of LSD-A case report on significant improvements in the absence of acute drug effects","volume":"11","author":"M\u00fcller","year":"2020","journal-title":"Front. Psychol."},{"issue":"38","key":"10.1016\/j.pnpbp.2024.110951_bb0465","doi-asserted-by":"crossref","first-page":"15171","DOI":"10.1523\/JNEUROSCI.2063-13.2013","article-title":"Broadband cortical desynchronization underlies the human psychedelic state","volume":"33","author":"Muthukumaraswamy","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2023.100623","article-title":"Effects of hydrogen gas inhalation on L-DOPA-induced dyskinesia","volume":"30","author":"Nascimento","year":"2023","journal-title":"Brain, Behavior, & Immunity - Health"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.110951_bb0475","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/0269881115596156","article-title":"The link between use of psychedelic drugs and mental health problems","volume":"29","author":"Nesv\u00e5g","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0480","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Therap."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0485","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110951_bb0490","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1748-1716.2008.01853.x","article-title":"5-HT 1A, but not 5-HT 2 and 5-HT 7, receptors in the nucleus raphe magnus modulate hypoxia-induced hyperpnoea","volume":"193","author":"Nucci","year":"2008","journal-title":"Acta Physiol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0495","first-page":"295","article-title":"Drugs and mysticism","volume":"8","author":"Pahnke","year":"1966","journal-title":"Int. J. Parapsychol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110951_bb0505","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110951_bb0510","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/scan\/nsy017","article-title":"Amygdala\u2013medial prefrontal cortex connectivity relates to stress and mental health in early childhood","volume":"13","author":"Park","year":"2018","journal-title":"Soc. Cogn. Affect. Neurosci."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.110951_bb0515","article-title":"The effect of brain serotonin deficiency on breathing is magnified by age","volume":"10","author":"Pho","year":"2022","journal-title":"Phys. Rep."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110951_bb0520","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/jts.22696","article-title":"Sleep quality improvements after MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder","volume":"34","author":"Ponte","year":"2021","journal-title":"J. Trauma. Stress."},{"issue":"18","key":"10.1016\/j.pnpbp.2024.110951_bb0525","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1073\/pnas.1524187113","article-title":"Effects of serotonin 2A\/1A receptor stimulation on social exclusion processing","volume":"113","author":"Preller","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0530","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35082","article-title":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","volume":"7","author":"Preller","year":"2018","journal-title":"eLife"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110951_bb0535","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1073\/pnas.1815129116","article-title":"Effective connectivity changes in LSD-induced altered states of consciousness in humans","volume":"116","author":"Preller","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.110951_bb0540","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s00213-018-5049-7","article-title":"Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting","volume":"235","author":"Prochazkova","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0545","author":"Raote"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.110951_bb0550","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.biopsych.2014.03.029","article-title":"Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression","volume":"76","author":"Riva-Posse","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.110951_bb0560","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"Journal of psychopharmacology (Oxford, England)"},{"issue":"9\u201310","key":"10.1016\/j.pnpbp.2024.110951_bb0565","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1111\/ejn.15080","article-title":"Intra-amygdala metaplasticity modulation of fear extinction learning","volume":"55","author":"Saha","year":"2022","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110951_bb0570","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","article-title":"Antidepressant effects of a single dose of Ayahuasca in patients with recurrent depression: A SPECT study","volume":"36","author":"Sanches","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110951_bb0575","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s42003-023-05073-w","article-title":"Intermediately synchronised brain states optimise trade-off between subject specificity and predictive capacity","volume":"6","author":"Sasse","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0580","article-title":"Grounded in biology: why the context-dependency of psychedelic drug effects means opportunities, not problems for anthropology and pharmacology","volume":"13","author":"Schleim","year":"2022","journal-title":"Front. Psychol."},{"issue":"23","key":"10.1016\/j.pnpbp.2024.110951_bb0585","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1523\/JNEUROSCI.20-23-08846.2000","article-title":"DOI-induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons","volume":"20","author":"Scruggs","year":"2000","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110951_bb0590","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(03)00547-0","article-title":"The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats","volume":"346","author":"Scruggs","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"3212","key":"10.1016\/j.pnpbp.2024.110951_bb0595","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.124.3212.121","article-title":"Some serotoninlike activities of lysergic acid diethylamide","volume":"vol. 124","author":"Shaw","year":"1956","journal-title":"Science New York, N.Y."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110951_bb0600","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/02698811231179800","article-title":"Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: relationship to symptoms","volume":"37","author":"Skosnik","year":"2023","journal-title":"Journal of psychopharmacology (Oxford, England)"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110951_bb0605","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/02698811231154852","article-title":"Psilocybin-assisted therapy for major depressive disorder: an exploratory placebo-controlled, fixed-order trial","volume":"37","author":"Sloshower","year":"2023","journal-title":"Journal of psychopharmacology (Oxford, England)"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110951_bb0610","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/wcs.58","article-title":"Analyzing effective connectivity with functional magnetic resonance imaging","volume":"1","author":"Stephan","year":"2010","journal-title":"Wiley Interdiscip. Rev. Cogn. Sci."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0615","series-title":"Storming Heaven: LSD and the American Dream","author":"Stevens","year":"1987"},{"issue":"8","key":"10.1016\/j.pnpbp.2024.110951_bb0620","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0269881121998321","article-title":"A qualitative and quantitative account of patient\u2019s experiences of ketamine and its antidepressant properties","volume":"35","author":"Sumner","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0625","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2014.03.046","article-title":"The analgesia effect of duloxetine on post-operative pain via intrathecal or intraperitoneal administration","volume":"568","author":"Sun","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0630","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fphar.2018.00172","article-title":"Unifying theories of psychedelic drug effects","volume":"9","author":"Swanson","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"14","key":"10.1016\/j.pnpbp.2024.110951_bb0635","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1503\/cmaj.141124","article-title":"Psychedelic medicine: a re-emerging therapeutic paradigm","volume":"187","author":"Tupper","year":"2015","journal-title":"CMAJ"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0640","article-title":"Psychedelics and other Psychoplastogens for treating mental illness","volume":"12","author":"Vargas","year":"2021","journal-title":"Front. Psychol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.110951_bb0650","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0361-9230(01)00646-3","article-title":"A systems model of altered consciousness: integrating natural and drug-induced psychoses","volume":"56","author":"Vollenweider","year":"2001","journal-title":"Brain Res. Bull."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.110951_bb0655","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.110951_bb0660","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"Von Rotz","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.pnpbp.2024.110951_bb0665","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euroneuro.2023.07.003","article-title":"The potential of psychedelics for the treatment of Alzheimer\u2019s disease and related dementias","volume":"76","author":"Winkelman","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110951_bb0670","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.40.4.228","article-title":"A biochemical and pharmacological suggestion about certain mental disorders","volume":"40","author":"Woolley","year":"1954","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110951_bb0680","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12264-022-00933-7","article-title":"Non-hallucinogenic psychedelic analog design: A promising direction for depression treatment","volume":"39","author":"Yin","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110951_bb0690","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-020-05692-9","article-title":"Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial","volume":"238","author":"Zeifman","year":"2021","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110951_bb0695","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neuron.2014.10.003","article-title":"Descending control of itch transmission by the serotonergic system via 5-HT1A-facilitated GRP-GRPR signaling","volume":"84","author":"Zhao","year":"2014","journal-title":"Neuron"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:07:10Z","timestamp":1759522030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":130,"alternative-id":["S0278584624000198"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110951","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of psychedelics: History, advancements, and unexplored frontiers","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110951"}}